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ABSTRACT
Background: Biliary tumors have low incidence in cats and are more common in elderly animals. Hepatobiliary tumors 
have different classifications and their etiology is difficult to interpret. In most cases, the diagnosis is only possible in ad-
vanced stages, which clouds the precursor factors. The late diagnosis is explained by the absence or specificity of clinical 
manifestations and laboratory changes. The majority of hepatobiliary neoplasms in cats are incidental findings in surgeries 
or necropsies. This study aimed to report clinical, laboratory, pathological and immunohistochemical results in a feline 
case of gallbladder adenocarcinoma.
Case: 4-year-old male castrated mix breed cat was admitted at a veterinary clinic with a history of polyuria / polydipsia, 
anorexia, apathy, jaundice and emesis for 60 days. The animal had been treated in another clinic with silymarin, famotidine 
and cyanocobalamin, and fed by esophageal tube based on the presumptive clinical diagnosis of cholangitis. The clinical 
examination revealed jaundice, abdominal pain, weight loss, enlargement of the liver and gallbladder and the presence of a 
structure in the epigastric region. Based on clinical signs, blood tests (complete blood count and liver enzymes), abdominal 
ultrasound and thoracic radiography were requested. In the exam results, eosinophilia, bilirubinemia and increased alkaline 
phosphatase, glutamic pyruvic transaminase and gamma glutamyl transferase were observed, in addition to the presence 
of icteric and hemolyzed serum. Ultrasound exam revealed thickened and dilated cystic and common ducts, large and 
thick gallbladder, bile with bile mud, hypoechogenic liver, thickening in the duodenal papilla and enlarged pancreatic and 
duodenal lymph nodes. There were no alterations in thoracic radiography. Based on the findings, the diagnosis of extrahe-
patic biliary obstruction was suggested. In celiotomy, dilated gallbladder with a thick blackened wall was observed. Bile 
puncture was performed for analysis, and total cholecystectomy and removal of obstructive content was performed. The 
patient suffered cardiorespiratory arrest after the procedure. A fragment of gallbladder and liver were sent to evaluation 
with histopathology and immunohistochemistry, and results were compatible with gallbladder adenocarcinoma.
Discussion: Hepatobiliary neoplasms in cats are uncommon, apart from lymphoma. The incidence is higher in elderly cats 
and in males, which did not match the animal in this case. The clinical presentation of the condition is quite nonspecific, 
corroborating with other reports, in which changes are often only evident in advanced stages of the disease. Laboratory 
and imaging findings pointed to a biliary tree disorder, and cholangitis was suggested. However, the lack of clinical im-
provement and examination findings of exams lead to an exploratory laparotomy for better inspection of the organs and 
identification of possible causes. One of the differential diagnoses that should be considered in cats with extrahepatic 
biliary obstruction is gallbladder adenocarcinoma, especially in animals with an unsatisfactory response in clinical treat-
ment. Tests such as histopathology and immunohistochemistry are essential for the definitive diagnosis of this neoplasm. 
Surgical resection is indicated in cases of malignant masses, providing longevity and better quality of life. Hypotension 
is a common complication in hepatobiliary surgeries, which can result in death. 
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INTRODUCTION
Primary gallbladder neoplasms are rare in cats, 
in which incidence values vary from 1 to 3% among di-
fferent types [11]. These conditions are more common 
in elderly animals and breed-related predispositions 
have not been reported [1]. 
Hepatobiliary neoplasms are classified as 
hepatocellular adenomas, hepatocellular adenocarci-
nomas, cholangiocellular adenomas, cholangiocellular 
adenocarcinomas or mesenchymal tumors. The cho-
langiocellular adenocarcinomas include intrahepatic 
bile duct adenocarcinomas, extrahepatic bile duct 
adenocarcinomas and gallbladder carcinomas [3].
The etiologies of gallbladder tumors are hard to 
interpret. In most cases, diagnosis is confirmed only in 
advance stages of the disease, which hinders the identi-
fication of precursor lesions [7]. Late diagnosis may be 
explained by the clinical presentation that is absent in 
50% of cases and is composed by nonspecific signs, such 
as inappetence, weight loss, lethargy and emesis [6].
Laboratory alterations, such as the increased 
levels of serum liver enzymes are also unspecific [1]. 
Hence, half the cases of hepatobiliary tumors in cats 
are incidental findings of surgeries or necropsies [4]. 
This study aimed to report clinical, laborato-
rial, pathological and immunohistochemical findings 
in a case of gallbladder adenocarcinoma in a cat.
CASE 
A 4-year-old male castrated mix breed cat was 
admitted at a veterinary clinic for consultation. Accor-
ding to the owner, the individual presented a history 
of apathy, polyuria/polydipsia, anorexia, emesis and 
jaundice for 60 days. Based on a previous diagnosis of 
cholangitis in another clinic, the individual was being 
treated orally for 40 days with Silymarin1 [40 mg/kg, 
twice a day  BID], Famotidine2 [1 mg/kg, once a day 
- SID], and with Cyanocobalamin3 [250 µg, via sub-
cutaneous injections every 7 days]. Patient was being 
fed through an esophageal tube with hypercaloric pasty 
feed for 30 days. In the clinical examination, emacia-
tion was observed with a body score of 4 (1-9 scale). 
In addition, the individual presented jaundice in skin 
and mucosa, hepatomegaly, abdominal pain and a mass 
was identified in the epigastric region. In view of the 
situation, some tests were requested, such as complete 
blood count, biochemical enzyme activity (direct-
-bilirubin, free-bilirubin, indirect-bilirubin, Alkaline 
Phosphatase - AP, Glutamic Pyruvic Transaminase 
- GPT and Gamma-Glutamyl Transferase - GGT), 
total abdominal ultrasound and thoracic radiography. 
Leukogram results demonstrated intense eo-
sinophilia (2.624 cells/µL - reference: 0-1,500 cells/
µL/L). Serum biochemical profile presented elevated 
levels of bilirubin (Direct bilirubin 11.4 mg/dL - re-
ference: 0.30 mg/dL; Indirect bilirubin 4.6 mg/dL 
- reference: 0.0-0.5 mg/dL) liver enzymes (FA 255 
mg/dL - reference: 25.0-93.0 mg/dL; TGP 527 mg/dL 
- reference: 6.0-83.00 mg/dL; GGT 40.00 mg/dL - refe-
rence: 1.3-5.10 mg/dL), icteric and hemolyzed serum. 
In abdominal ultrasonography, the liver pre-
sented reduced and gross echogenicity with no eviden-
ce of nodules or cysts. Gallbladder presented severely 
thick echogenic walls (0.35 cm), anechoic bile with 
hypoechoic content in the lowest part (biliary mud). 
Cystic and common ducts were dilated (0.46 cm and 
0.29 cm in diameter, respectively) and thick (0.09 cm 
in both). Duodenum was also thick in the duodenal 
papilla (0.30 cm) and pancreatic parenchyma was sli-
ghtly hypoechoic. Lymphadenomegaly was observed 
in pancreatic and duodenal lymph nodes. Thoracic 
radiography did not present alterations.  
Considering the case and the unsatisfactory the-
rapeutic response, a possible diagnosis of extrahepatic 
biliary obstruction was considered. Hence, a surgical 
approach was suggested to perform a bilioenteric bypass. 
Maintenance fluid therapy was recommended, and pain 
was managed using Meloxicam4 [0.05 mg/kg, SC, SID] 
for 3 days. The animal was submitted to surgery, in 
which pre-anesthesia consisted of Methadone5 [0.3 mg/
kg, SC] and Dexmedetomidine6 (3 m/kg, SC). Isoflurane 
was used for induction via mask and in maintenance at 
2%. In the celiotomy, gallbladder was severely dilated 
(Figure 1) and manual decompression was not possible. 
In addition, the left liver duct, cystic duct and common 
bile duct were ingurgitated. Gallbladder walls were 
thick and dark. Hyperemia was observed in proximal 
duodenal walls, omentum and peripancreatic fat, in 
addition to lymphadenomegaly. Based on these findin-
gs, total cholecystectomy was performed. At the end of 
surgery, a severe hypotension occurred, which resulted 
in cardiorespiratory arrest. Resuscitation protocol was 
performed with no success. A bile sample was collected 
for cytology and bacterial culture. The excised gallblad-
der and a liver fragment were sent for histopathological 
analysis. Bacterial culture was negative and cytology 
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results demonstrated squamous epithelial cells, neutro-
phils, macrophages and amorphous acellular material 
with no evidence of bacteria or parasite eggs. 
In histopathological examination, marked 
proliferation of unencapsulated carcinoma epithelial 
cells which infiltrated the mucosa and submucosa of 
the gallbladder was observed. Neoplastic cells formed 
irregular acini and papillary structures, which were 
sustained by abundant fibrovascular stroma (marked 
desmoplasia) [Figure 2A] . Multifocal intramural in-
flammatory infiltrate of neutrophils and eosinophils 
was observed. Tumoral clots were seen in lymph and 
blood vessels, in addition to necrotizing vasculitis 
and fibrin thrombi in submucosal vessels. In the liver 
fragment adjacent to the gallbladder, discrete fibrosis 
and marked proliferation of periportal biliary ducts 
was observed. In addition, a fine diffuse hepatocellular 
vacuolization was identified. 
According to the histopathological findings, 
gallbladder adenocarcinoma was diagnosed. Samples 
from these tissues were submitted to immunohistoche-
mical analysis, in which four biomarkers were used 
in the peroxidase streptavidin-biotin technique with 
the monoclonal antibodies Anti-Hepatocyte Specific 
Antigen (Clone OCH1E5)7, Anti-CK Pan (Clone AE-
1AE3)8, Anti-CK7 (Clone OV-TL12/30)9 and CK20 
(Clone Ks20.8)9. Immune expressions for CK Pan and 
CK7 were observed, which confirmed the diagnosis 
(Figure 2B,D) [Figure 2C].
DISCUSSION
Hepatobiliary neoplasia in cats is relatively un-
common with the exception of lymphomas [9]. A study 
conducted by Patnaik [10], demonstrated that among 
hepatobiliary tumors in cats, those of epithelial origin 
and biliary system were most frequent, unlike humans 
and dogs, in which liver neoplasia are more common. 
Primary hepatobiliary tumors occur more fre-
quently in older and male individuals with average age 
between nine and ten years [12]. However, the animal 
in this case was much younger (4-year-old). 
Clinical presentation presented by the cat in 
this report consisted of apathy, anorexia and emesis, 
which are unspecific. This finding corroborates with 
[9] that reported these signs in hepatobiliary cases. Ac-
cording to Liptak et al. [6], only 50% of hepatobiliary 
neoplasia cases in cats present clinical manifestations, 
which are nonspecific and mostly identified in advan-
ced stages of the disease. Other clinical manifestations 
include weight loss, jaundice, hepatomegaly, polyuria 
and polydipsia [4,12].
The main biochemical alterations that were 
identified in this case are unspecific for the tumor and 
could occur in several conditions affecting liver and 
biliary tree, including increased liver transaminases 
and bilirubin [9]. Other expected laboratory findings 
include neutrophilia and chronic anemia, which were 
not observed in this report [1].
Clinical and laboratory alterations suggested 
the initial diagnosis of cholangitis. However, the lack 
of improvement after the clinical treatment and the 
ultrasonographic findings suggestive of obstructive 
condition, especially due to the dilation of common 
and cystic ducts led to the extrahepatic biliary duct 
obstruction diagnosis [2]. In addition, the presence of 
biliary mud suggests cholestasis, which is considered 
a significant finding in cats [4].
This condition may occur as a consequence of 
chronic cholangitis, pancreatitis, gallstones, parasite 
infestation and neoplasms [9]. Hence, all of these 
conditions are considered as differential diagnoses of 
gallbladder adenocarcinoma. Surgical exploration for 
biliary decompression and inspection of liver and other 
organs is recommended when the cause is not iden-
tified or in the absence of clinical improvement after 
the treatment is initiated [2], which was the procedure 
adopted in this case. 
Neoplasm was demonstrated by the malignant 
epithelial cell infiltrate in mucosa and submucosa of the 
gallbladder. These cells presented immune expression 
by CK7, which marks ductal, glandular, superficial 
squamous and transition epitheliums, and by CK Pan, 
which is a specific antigen marker of filaments of 
epithelial cells that characterizes adenocarcinoma [5].
Surgical resection is indicated to provide 
better duration and quality of life for the animal [12]. 
Chemotherapy does not present adequate results in the 
treatment of primary hepatobiliary tumors [1]. During 
surgery, the occurrence of hypotension is common in 
cat anesthesia during procedures involving gallbladder 
and biliary tree, which can result in death [8] as occur-
red in this case. A mechanism that may affect muscle 
tonus in these patients is the presence of increased 
bilirubin concentrations in blood. In addition, a possi-
ble increased liberation of nitric oxide associated with 
obstructive jaundice have been reported in dogs [8].
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Prognosis for malignant hepatobiliary neopla-
sia is unfavorable with elevated metastasis rates [3], 
which were not observed in this case. However, the 
possibility was clear, considering the tumoral clots 
identified in histopathological analysis. 
The gallbladder adenocarcinoma should be 
considered as a differential diagnosis for extrahepatic 
biliary obstruction in cats, especially in cases that are 
unresponsive to clinical treatment. Histopathology and 
immunohistochemistry are key tests to confirm the 
presence of this neoplasia. Despite the risk of death 
during surgery, the indicated treatment is surgical 
resection with the aim to promote better quality of life 
for the animal. 
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6Zoetis Inc. Parsippany, NJ, USA.Figure 1. Gallbladder carcinoma in a cat. Marked dilation and thickening 
of gallbladder walls.
Figure 2. Gallbladder carcinoma in a cat. A- Marked proliferation of carcinoma cells with acini-like structures. Cell morphology range from polygonal 
to cuboidal with scarce to moderate eosinophilic cytoplasm. Nuclei are round to oval with vacuolated chromatin and evident nucleoli [H.E.; Obj. 20x]. 
B- Intense cytoplasmatic immune marking of epithelial cells for CK Pan [Obj. 10x]. C- Moderate cytoplasmatic immune marking of epithelial cells for 
CK7 [Obj. 40x]. D- Intense cytoplasmatic immune marking of epithelial cells for CK Pan [Obj. 20x].
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